LIVE
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

SYNGENE

NSEBSE
Syngene International Limited
Healthcare· Healthcare Services· INE398R01022· Scrip: 539268
ENहिन्दीગુજરાતીमराठी
468.55
36.40 (+8.42%)
30/4/2026, 3:28:56 pm
NSE
468.55
36.40
+8.42%
BSE
467.90
35.85
+0.00%
38947355764172604-3006-2608-2210-2112-1802-1704-2404-30
245 trading days · 1Y period
TODAY
Open431.95
High518.55
Low429.90
Prev Close432.15
Volume5.91Cr
Value₹2854.6Cr
L: 429.90H: 518.55
52 WEEK
Low380.00
High728.60
25% of 52W range
Info
Face Value₹10
Listed2015-08-11
ISININE398R01022
SeriesA
BSE Scrip539268

Key Metrics

1D
+8.42%
1W
+9.38%
1M
+17.48%
3M
-22.68%
6M
-26.63%
Valuation
Mkt Cap₹15840 Cr
Growth (QoQ)
Revenue+5.91%
PAT+23.56%
EPS+23.86%
Profitability
Dividend
Yield0.27%
Latest DPS₹1.25
Growth+0.00%
TTM Revenue
₹3478 Cr
TTM EBITDA
₹1048 Cr
TTM PAT
₹500 Cr
TTM EPS
₹12.45
Rev/Share
₹86.3

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr249 Cr497 Cr746 Cr994 Cr22-1223-0323-0923-1224-0324-0624-0924-122.74.52.92.84.71.82.63.3
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-31944 Cr781 Cr290 Cr181 Cr131 Cr3.27
2024-09-30891 Cr770 Cr248 Cr137 Cr106 Cr2.64
2024-06-30727 Cr677 Cr191 Cr99 Cr74 Cr1.84
2024-03-31917 Cr724 Cr320 Cr209 Cr189 Cr4.70
2023-12-31854 Cr741 Cr246 Cr138 Cr112 Cr2.78
2023-09-30910 Cr774 Cr255 Cr151 Cr117 Cr2.90
2023-03-31994 Cr786 Cr327 Cr231 Cr179 Cr4.46
2022-12-31786 Cr663 Cr235 Cr140 Cr110 Cr2.74

Shareholding Pattern

CURRENT2026-03-31
52.7%PROMOTER
Promoter52.7%
FII13.9%
DII26.4%
Public47.0%
PROMOTER HOLDING TREND
54.7%24-0654.7%24-0952.7%24-1252.7%25-0352.7%25-0952.7%25-1252.7%26-03

Corporate Actions

Ex-DateTypePurpose
2025-06-27DividendDividend - Rs 1.25 Per Share
2024-06-28DividendDividend - Rs 1.25 Per Share
2023-06-30DividendDividend - Rs 0.50 Per Share/Special Dividend - Rs 0.75 Per Share
2022-06-30DividendDividend - Rs 0.50 Per Share/Special Dividend - Rs 0.50 Per Share
2021-07-13Other Annual General Meeting
2019-07-16Dividend Dividend - Rs 0.50 Per Share
2019-06-11Bonus Bonus 1:1
2018-07-17Dividend Dividend Re - Re 1 Per Share
2017-07-20Dividend Dividend - Rs 1/- Per Share
2016-03-17Dividend Interim Dividend - Re 1/- Per Share (Purpose Revised)

Earnings Transcripts

Syngene International Limited has informed the Exchange about Investor Presentation
17 Dec 2025NSE18K chars
Read →
Syngene International Limited has informed the Exchange about Investor Presentation
6 Nov 2025NSE33K chars
Read →
Syngene International Limited has informed the Exchange about Investor Presentation
9 Sept 2025NSE11K chars
Read →
Syngene International Limited has informed the Exchange about Investor Presentation
24 Jul 2025NSE32K chars
Read →
Syngene International Limited has informed the Exchange about Investor Presentation
12 Mar 2025NSE13K chars
Read →
Syngene International Limited has informed the Exchange about Investor Presentation
23 Jan 2025NSE32K chars
Read →
Syngene International Limited has informed the Exchange regarding 'Revised Intimation of Conference ...
17 Jan 2025NSE6K chars
Read →
Syngene International Limited has informed the Exchange about Investor Presentation
25 Jan 2024NSE32K chars
Read →
Syngene International Limited has informed the Exchange about Investor Presentation
17 Oct 2023NSE32K chars
Read →
Syngene International Limited has informed the Exchange about Investor Presentation
26 Jul 2023NSE33K chars
Read →
Syngene International Limited has informed the Exchange about link for the audio recording of the Q4...
27 Apr 2023NSE2K chars
Read →
Syngene International Limited has informed the Exchange about Investor Presentation
26 Apr 2023NSE37K chars
Read →
Syngene International Limited has informed the Exchange about Investor Presentation
23 Jan 2023NSE37K chars
Read →
Syngene International Limited has informed the Exchange about Transcript of Analysts/Institutional I...
25 Oct 2022NSE1K chars
Read →
Syngene International Limited has informed the Exchange about Investor Presentation
19 Oct 2022NSE36K chars
Read →
Syngene International Limited has informed the Exchange about Transcript of Analysts/Institutional I...
26 Jul 2022NSE1K chars
Read →
Syngene International Limited has informed the Exchange about Investor Presentation
20 Jul 2022NSE40K chars
Read →
Syngene International Limited has informed the Exchange about Transcript of Analysts/Institutional I...
4 May 2022NSE2K chars
Read →
Syngene International Limited has informed the Exchange about Investor Presentation
27 Apr 2022NSE45K chars
Read →
Syngene International Limited has informed the Exchange about Conference Call for Analysts and Inves...
22 Apr 2022NSE5K chars
Read →

Price History

DateOpenHighLowCloseVolume
2026-04-30431.95518.55429.90467.655.93Cr
2026-04-29440.25443.95429.90432.156.31L
2026-04-28435.00445.60434.10440.258.17L
2026-04-27423.00440.90421.25437.956.48L
2026-04-24430.00432.55417.45421.206.48L
2026-04-23431.00442.40427.00428.358.49L
2026-04-22448.00449.70430.00435.957.44L
2026-04-21436.00450.95434.85444.659.98L
2026-04-20440.00443.50433.15436.454.46L
2026-04-17438.90441.50430.80436.605.39L
2026-04-16417.95439.25417.95434.7014.64L
2026-04-15407.40418.30405.00415.009.36L
2026-04-13400.00403.90391.75402.855.11L
2026-04-10399.00411.80395.10404.6525.68L
2026-04-09402.40405.40390.25393.109.36L
2026-04-08399.45402.40395.65399.0517.59L
2026-04-07400.00402.30390.00390.9015.06L
2026-04-02392.55393.20380.05391.105.36L
2026-04-01395.05404.50390.45396.4013.77L
2026-03-27419.00426.15402.75415.6040.20L
2026-03-25402.00423.30402.00418.7527.48L
2026-03-24402.50406.15395.05398.859.09L
2026-03-20407.85417.80407.85414.7510.85L
2026-03-19415.00419.80406.25407.855.75L
2026-03-18412.10426.35412.10419.858.94L
2026-03-17409.50415.30407.80411.058.18L
2026-03-16424.35426.20405.45410.1518.06L
2026-03-13405.90428.00405.00420.8597.87L
2026-03-12407.30408.60396.20404.106.32L
2026-03-11409.00416.85405.50408.156.15L

Frequently Asked Questions

About

Syngene International Limited, listed on the National Stock Exchange of India (NSE) as SYNGENE, is a prominent contract research and manufacturing company specializing in drug discovery and development services with operations spanning India, the United States, Europe, and internationally. The company offers key services including custom screening, fragment-based drug design, and cell and gene therapy solutions, catering to the pharmaceutical and biotechnology industries. Founded in 2000, Syngene has established itself as a leading player in the CDMO (Contract Development and Manufacturing Organization) space, serving clients globally with its innovative and scalable service model.

BOARD OF DIRECTORS
Carl Decicco
Executive Director
DEPARTED
Sibaji Biswas
Executive Director
DEPARTED
Vinita Bali
Executive Director
Manja Boerman
Independent Director
Nilanjan Roy
Independent Director
Sharmila Abhay Karve
Independent Director